Ergebnisse für *

Zeige Ergebnisse 1 bis 12 von 12.

  1. Re-thinking global and local manufacturing of medical products after COVID-19
    Erschienen: 2020
    Verlag:  South Centre, Geneva

  2. Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19
    Erschienen: 2021
    Verlag:  South Centre, Genève

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
  3. The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
    Erschienen: 2020
    Verlag:  South Centre, Geneva

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
  4. Equitable access to COVID-19 related health technologies
    a global priority
    Erschienen: 2020
    Verlag:  South Centre, Geneva

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
  5. Guide for the granting of compulsory licenses and government use of pharmaceutical patents
    Erschienen: 2020
    Verlag:  South Centre, Geneva

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    Universitätsbibliothek Braunschweig
    keine Fernleihe
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
  6. Guía para la concesión de licencias obligatorias y uso gubernamental de patentes farmacéuticas
    Erschienen: 2020
    Verlag:  South Centre, Ginebra

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Spanisch
    Medientyp: Buch (Monographie)
    Format: Online
    Weitere Identifier:
    hdl: 10419/232228
    Schriftenreihe: Documento de investigación / South Centre ; 107 (Diciembre de 2020)
    Schlagworte: Access to Medicines; Affordable Medicines; Compulsory Licenses; COVID-19; Data Exclusivity; Diagnostics; Doha Declaration on the TRIPS Agreement and Public Health; Evergreening; Flexibilities; Global Health; Government Use; Health; Innovation; Intellectual Property; Least Developed Countries (LDCs); Patent; Pharmaceuticals; Public Health; Research and Development (R&D); TRIPS; Vaccines; Voluntary License; WHO; WHO Global Strategy (GSPOA); World Health Organization (WHO)
    Umfang: 1 Online-Ressource (circa 44 Seiten), Illustrationen
  7. The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines
    Erschienen: 2021
    Verlag:  South Centre, Geneva

    Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of... mehr

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe

     

    Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production, and the uneven distribution of options of vaccine doses already approved for use. This pattern of production restrictions and unequal access will lead to an increase in international inequalities, leaving a large part of the world to have access to vaccines not until 2024. While advanced purchase agreements (APAs) among pharmaceutical companies and some developed countries are multiplying, the proposed mechanisms for voluntary licensing of technologies and the COVAX Facility do not achieve their goal of democratizing access to vaccines. In this sense, the current TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) waiver proposal seems to be the political and institutional response with the greatest potential to guarantee the scaling of the production of pharmaceutical inputs, allowing the adoption of a comprehensive strategy to ensure timely, sufficient, and affordable access to all technologies developed to fight COVID-19.

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
  8. The WTO TRIPS decision on COVID-19 vaccines
    what is needed to implement it?
    Erschienen: [2022]
    Verlag:  South Centre, Geneva, Switzerland

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from... mehr

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe

     

    The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from certain obligations under the TRIPS Agreement for health products and technologies for the prevention, treatment and containment of COVID-19. The adopted Decision only waives the obligation under article 31 (f) of the TRIPS Agreement. Developing country WTO members are now allowed to export any proportion of vaccines, including ingredients and processes, necessary for the COVID-19 pandemic that are manufactured under a compulsory license or government use authorization to other developing countries. It also contains some clarifications of relevant TRIPS provisions, while introducing a number of conditionalities that are not present in the TRIPS Agreement. This paper examines the object and scope of the Decision, the requirements established for its use, and the required actions to be taken by WTO members to implement it.

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    Format: Online
    Weitere Identifier:
    hdl: 10419/278266
    Schriftenreihe: Research paper / South Centre ; 169 (8 November 2022)
    Schlagworte: Compulsory Licenses; COVID-19; Diagnostics; Dispute Settlement; Doha Declaration on the TRIPS Agreement and Public Health; Flexibilities; Government Use; MC12; Pandemic; Parallel Importation; Test Data; Therapeutics; TRIPS; TRIPS Agreement; TRIPS Flexibilities; TRIPS Waiver; Vaccines; Voluntary License; World Trade Organization (WTO); WTO TRIPS Decision on COVID-19 Vaccines
    Umfang: 1 Online-Ressource (circa 36 Seiten)
  9. Left on our own
    COVID-19, TRIPS-Plus Free Trade Agreements, and the Doha Declaration on TRIPS and Public Health
    Erschienen: [2022]
    Verlag:  South Centre, Geneva, Switzerland

    The cusp of the twentieth anniversary of the WTO Doha Declaration on the TRIPS Agreement and Public Health (hereafter "the Declaration") was marked by a global pandemic. The Declaration and its iteration in the Agreement on Trade Related Aspects of... mehr

    Zugang:
    Verlag (kostenfrei)
    Verlag (kostenfrei)
    Resolving-System (kostenfrei)
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 751
    keine Fernleihe

     

    The cusp of the twentieth anniversary of the WTO Doha Declaration on the TRIPS Agreement and Public Health (hereafter "the Declaration") was marked by a global pandemic. The Declaration and its iteration in the Agreement on Trade Related Aspects of Intellectual Property Rights (hereafter "TRIPS") Article 31 bis, should have helped to contain the devastation in least developed and developing countries. The reality is that the pandemic is still ongoing, and the Global South led by South Africa and India are seeking a waiver of provisions to the TRIPS Agreement to ensure that COVID-19 therapeutics, diagnostics, and vaccines reach their citizens in order to contain the spread of the COVID-19 virus ("the TRIPS waiver"). These citizens are especially vulnerable because of their inability to access vaccines due to their prices and supply shortages caused by the refusal to share manufacturing technology. The Doha Declaration aimed at reaffirming the interpretation and implementation of the TRIPS Agreement to support WTO members' right to protect public health and promote access to medicines. However, the operationalization of the Declaration via Article 31bis of TRIPS has been cumbersome and procedurally difficult to navigate. This paper argues that the current iteration of the Doha Declaration within TRIPS fails to meet the objectives of the Declaration as demonstrated by the need for a further waiver of the TRIPS agreement. It also attempts to "reimagine" Article 31 bis in light of the TRIPS waiver from the position of the Global South to make it more equitable and practicable and maintain the spirit of the Declaration.

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    Format: Online
    Weitere Identifier:
    hdl: 10419/278267
    Schriftenreihe: Research paper / South Centre ; 170 (17 November 2022)
    Schlagworte: Access to Medicines; Article 31bis; COVID-19; Diagnostics; Doha Declaration on the TRIPS Agreement and Public Health; Flexibilities; Free Trade Agreements (FTAs); Intellectual Property; Kenya; Pandemic; Paragraph 6; Public Health; Therapeutics; TRIPS; TRIPS Agreement; TRIPS Flexibilities; TRIPS Plus; TRIPS Waiver; United States-Kenya Free Trade Agreement (USKEFTA); Vaccines
    Umfang: 1 Online-Ressource (circa 36 Seiten)
  10. Diagnosis as cultural practice
    Erschienen: c2005
    Verlag:  Mouton de Gruyter, Berlin

    Ostbayerische Technische Hochschule Amberg-Weiden / Hochschulbibliothek Amberg
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Ostbayerische Technische Hochschule Amberg-Weiden, Hochschulbibliothek, Standort Weiden
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Hinweise zum Inhalt
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Ebook
    Format: Online
    ISBN: 3110199807; 9783110199802
    RVK Klassifikation: EC 2500 ; ER 990 ; ES 155 ; HF 143
    Schriftenreihe: Language, power, and social process ; 16
    Schlagworte: Diagnostics; Diagnostics / Études transculturelles; MEDICAL / Laboratory Medicine; MEDICAL / Diagnosis; MEDICAL / Nursing / Assessment & Diagnosis; Diagnosis; Cross-Cultural Comparison; Diagnosis; Medizin; Diagnosis; Diagnosis; Soziolinguistik; Soziale Situation; Arzt; Patient; Diagnose
    Umfang: 1 Online-Ressource (x, 307 p.)
    Bemerkung(en):

    Includes bibliographical references and indexes

    Diagnosis as an aid and a curse in dealing with others / Mary L. Foster-Galasso -- A diagnosed life in an institutional setting: can the dancer walk? / Barbara G. Bokhour -- From diagnostic to aesthetic: moving beyond diagnosis / Ozum Ucok -- Revisiting authority in physician-patient interaction / John Heritage -- "I just wanna know why": patients' attempts and physicians' responses to premature solicitation of diagnostic information / Charlotte M. Jones and Wayne A. Beach -- Aggravated resistance to problem formulations in therapy / G.H. Morris

    Learning to diagnose: production of diagnostic hypotheses in problem-based learning tutorials / Philip Glenn and Timothy Koschmann -- Emotion and objectivity in medical diagnosis / Dana Kovarsky, Linda K. Snelling, and Elayne Meyer -- The diagnostic practices of speech-language pathologists in America over the last century / Judith Felson Duchan

    The diagnosis of deafness in Nicaragua / Laura Polich -- Documenting awareness of the cultural process of diagnosis: letters of recommendation for medical school faculty / Frances Trix -- Speaking about menopause: possibilities for a cultural discourse analysis / Cindy Suopis and Donal Carbaugh -- The diagnosis of the constituents of communication in everyday discourse: some functions, enabling conditions, consequences, and remedies / Christian Nelson

  11. Diagnosis as cultural practice
    Erschienen: 2005
    Verlag:  Mouton de Gruyter, Berlin [u.a.]

    Freie Universität Berlin, Universitätsbibliothek
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Humboldt-Universität zu Berlin, Universitätsbibliothek, Jacob-und-Wilhelm-Grimm-Zentrum
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Staatsbibliothek zu Berlin - Preußischer Kulturbesitz, Haus Unter den Linden
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Verbund der Öffentlichen Bibliotheken Berlins - VÖBB
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Universität Potsdam, Universitätsbibliothek
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Philologische Bibliothek, FU Berlin; Staatsbibliothek zu Berlin
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    ISBN: 3110184664; 9783110184662; 3110184672; 9783110184679
    RVK Klassifikation: EC 2500 ; ER 990 ; ES 155 ; HF 143
    DDC Klassifikation: Medizin und Gesundheit (610)
    Schriftenreihe: Language, power and social process ; 16
    Schlagworte: Diagnostics; Diagnostics - Études transculturelles; Diagnosis; Diagnosis; Cross-Cultural Comparison; Soziale Situation; Patient; Arzt; Diagnose; Soziolinguistik
    Umfang: X, 307 S., Ill.
    Bemerkung(en):

    Includes bibliographical references and index

  12. Diagnosis as cultural practice
    Erschienen: 2005
    Verlag:  Mouton de Gruyter, Berlin [u.a.]

    Universitätsbibliothek Bayreuth
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Bayerische Staatsbibliothek
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Universitätsbibliothek Regensburg
    uneingeschränkte Fernleihe, Kopie und Ausleihe
    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Buch (Monographie)
    ISBN: 3110184664; 9783110184662; 3110184672; 9783110184679
    RVK Klassifikation: EC 2500 ; ER 990 ; ES 155 ; HF 143
    DDC Klassifikation: Medizin und Gesundheit (610)
    Schriftenreihe: Language, power and social process ; 16
    Schlagworte: Diagnostics; Diagnostics - Études transculturelles; Diagnosis; Diagnosis; Cross-Cultural Comparison; Soziale Situation; Patient; Arzt; Diagnose; Soziolinguistik
    Umfang: X, 307 S., Ill.
    Bemerkung(en):

    Includes bibliographical references and index